Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131 Article

Vogelbaum, Michael A, Berkey, Brian, Peereboom, David et al. (2009). Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131 . NEURO-ONCOLOGY, 11(2), 167-175. 10.1215/15228517-2008-073

Open Access International Collaboration

cited authors

  • Vogelbaum, Michael A; Berkey, Brian; Peereboom, David; Macdonald, David; Giannini, Caterina; Suh, John H; Jenkins, Robert; Herman, James; Brown, Paul; Blumenthal, Deborah T; Biggs, Christopher; Schultz, Christopher; Mehta, Minesh

sustainable development goals

authors

publication date

  • April 1, 2009

webpage

published in

keywords

  • 19Q
  • 1p/19q loss of heterozygosity
  • CHEMOTHERAPY
  • CHROMOSOME ARMS 1P
  • Clinical Neurology
  • EUROPEAN-ORGANIZATION
  • GLIOBLASTOMA
  • Life Sciences & Biomedicine
  • MGMT
  • Neurosciences & Neurology
  • Oncology
  • PREDICTORS
  • PROCARBAZINE
  • RADIOTHERAPY
  • RTOG
  • SURVIVAL
  • Science & Technology
  • TUMORS
  • oligodendroglioma
  • temozolomide

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 167

end page

  • 175

volume

  • 11

issue

  • 2